By Jaime Llinares Taboada

 

Koninklijke Philips N.V. said Friday that it is resuming the manufacturing and distribution of defibrillators in the U.S. after the Food and Drug Administration lifted its prohibition on those activities.

The health-technology group said it had been required to suspend those activities pending FDA certification of Philips' compliance with U.S. regulations.

 

Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT

 

(END) Dow Jones Newswires

April 24, 2020 03:38 ET (07:38 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Koninklijke Philips NV.
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Koninklijke Philips NV.